Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Influence of gender on the QT interval variability and duration in different wake-sleep stages in non-sleep apneic individuals: Analysis of polysomnographic recordings.

Viigimae M, Karai D, Pilt K, Polo O, Huhtala H, Meigas K, Kaik J.

J Electrocardiol. 2017 Jul - Aug;50(4):444-449. doi: 10.1016/j.jelectrocard.2017.03.012. Epub 2017 Mar 14.

PMID:
28363478
2.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

PMID:
28304224
3.

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.

4.

QT Interval Variability Index and QT Interval Duration in Different Sleep Stages: Analysis of Polysomnographic Recordings in Nonapneic Male Patients.

Viigimae M, Karai D, Pirn P, Pilt K, Meigas K, Kaik J.

Biomed Res Int. 2015;2015:963028. doi: 10.1155/2015/963028. Epub 2015 Nov 29.

5.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

6.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

7.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.

8.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

9.

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.

10.

Association between ventricular repolarization and main cardiovascular risk factors.

Pshenichnikov I, Shipilova T, Karai D, Riiupulk J, Veski K, Pilt K, Kaik J.

Scand Cardiovasc J. 2011 Feb;45(1):33-40. doi: 10.3109/14017431.2010.532232. Epub 2010 Nov 30.

PMID:
21114455
11.

An experimental measurement complex for probable estimation of arterial stiffness.

Pilt K, Meigas K, Viigimaa M, Temitski K, Kaik J.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:194-7. doi: 10.1109/IEMBS.2010.5627925.

PMID:
21097179
12.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
13.

Adjustment of adaptive sum comb filter for PPG signals.

Pilt K, Meigas K, Ferenets R, Kaik J.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5693-6. doi: 10.1109/IEMBS.2009.5333539.

PMID:
19964414
14.

Adaptive impulse correlated filter (AICF) improvement for photoplethysmographic signals.

Pilt K, Meigas K, Lass J, Rosmann M, Kaik J.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:273-6. doi: 10.1109/IEMBS.2008.4649143.

PMID:
19162646
15.

Analogue step-by-step DC component eliminator for 24-hour PPG signal monitoring.

Pilt K, Meigas K, Lass J, Rosmann M, Kaik J.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1006-9.

PMID:
18002130
16.

A novel method for reducing pain sensation at transesophageal atrial stimulation.

Anier A, Kaik J, Meigas K.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:923-6.

PMID:
18002108
17.

Continuous blood pressure monitoring during exercise using pulse wave transit time measurement.

Lass J, Meigas K, Karai D, Kattai R, Kaik J, Rossmann M.

Conf Proc IEEE Eng Med Biol Soc. 2004;3:2239-42.

PMID:
17272172
18.

Echocardiographic assessment of the different left ventricular geometric patterns in middle-aged men and women in Tallinn.

Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Meigas K.

Blood Press. 2003;12(5-6):284-90.

PMID:
14763659
19.

QT dispersion in relation to left ventricular geometry and hypertension in a population study.

Pshenichnikov I, Shipilova T, Kaik J, Volozh O, Abina J, Lass J, Karai D.

Scand Cardiovasc J. 2003 May;37(2):87-90.

PMID:
12775307
20.

Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.

Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Karai D.

Blood Press. 2003;12(1):12-8.

PMID:
12699130

Supplemental Content

Loading ...
Support Center